Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Zodiac Gold closes C$5.6M private placement one day late
• Buffalo Potash Announces Closing of C$14.01 Million First Tranche of Oversubscribed and Upsized C$14.85 Million Non-Brokered Private Placement